EcoDrugPlus


Keyword(s):	Human Metabolites
Molecule Category	Free-form
UNII	QWW4HNQ0L1
EPA CompTox	DTXSID30190140

Keyword(s):

Human Metabolites

Molecule Category

Free-form

UNII

QWW4HNQ0L1

EPA CompTox

DTXSID30190140


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70


InChI Key	PEBWOGPSYUIOBP-UHFFFAOYSA-N
Smiles	FC1=CC=C(F)C(F)=C1
InChI	InChI=1/C6H3F3/c7-4-1-2-5(8)6(9)3-4/h1-3H

InChI Key

PEBWOGPSYUIOBP-UHFFFAOYSA-N

Smiles

FC1=CC=C(F)C(F)=C1

InChI

InChI=1/C6H3F3/c7-4-1-2-5(8)6(9)3-4/h1-3H

Property Name	Value
Molecular Formula	C6H3F3
Molecular Weight	132.02
AlogP	2.1
Hydrogen Bond Acceptor	0.0
Hydrogen Bond Donor	0.0
Number of Rotational Bond	0.0
Polar Surface Area	0.0
Molecular species	None
Aromatic Rings	1.0
Heavy Atoms	9.0

Property Name

Value

Molecular Formula

C6H3F3

Molecular Weight

132.02

AlogP

2.1

Hydrogen Bond Acceptor

0.0

Hydrogen Bond Donor

0.0

Number of Rotational Bond

0.0

Polar Surface Area

0.0

Molecular species

None

Aromatic Rings

1.0

Heavy Atoms

9.0

Resources	Reference
CAS NUMBER	367-23-7
NORMAN SUSDAT
FDA SRS	QWW4HNQ0L1
PubChem	67773

Resources

Reference

CAS NUMBER

367-23-7

NORMAN SUSDAT

FDA SRS

QWW4HNQ0L1

PubChem

67773


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

1,2,4-TRIFLUOROBENZENE

Structure

Physicochemical Descriptors

Cross References